Variant report

Variant	nsv605889
Chromosome Location	chr7:3340187-3342276
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:538)
CpG islands
(count:613)
Chromatin interactive
region (count:4)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:538 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:3340510-3340769	HepG2	liver:	n/a	n/a
2	ARID3A	chr7:3340556-3340788	K562	blood:	n/a	n/a
3	BACH1	chr7:3341623-3341680	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr7:3339959-3340991	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCLAF1	chr7:3340441-3340719	GM12878	blood:	n/a	chr7:3340634-3340647 chr7:3340524-3340537
6	BCLAF1	chr7:3340395-3340873	GM12878	blood:	n/a	chr7:3340634-3340647 chr7:3340524-3340537 chr7:3340744-3340757
7	BHLHE40	chr7:3340404-3341008	K562	blood:	n/a	chr7:3340932-3340948 chr7:3340519-3340535 chr7:3340527-3340543
8	BHLHE40	chr7:3340387-3340937	GM12878	blood:	n/a	chr7:3340519-3340535 chr7:3340527-3340543
9	BHLHE40	chr7:3340409-3341002	HepG2	liver:	n/a	chr7:3340932-3340948 chr7:3340519-3340535 chr7:3340527-3340543
10	BRCA1	chr7:3340563-3340738	HepG2	liver:	n/a	n/a
11	CBX3	chr7:3340484-3340710	K562	blood:	n/a	n/a
12	CBX3	chr7:3340323-3340885	HCT-116	colon:	n/a	n/a
13	CBX3	chr7:3340439-3340719	K562	blood:	n/a	n/a
14	CCNT2	chr7:3340411-3341005	K562	blood:	n/a	n/a
15	CHD1	chr7:3340292-3340917	IMR90	lung:	n/a	n/a
16	CHD2	chr7:3340488-3340695	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr7:3340511-3340673	HepG2	liver:	n/a	n/a
18	CHD2	chr7:3340519-3340719	GM12878	blood:	n/a	n/a
19	CHD2	chr7:3340606-3340636	K562	blood:	n/a	n/a
20	CREB1	chr7:3340132-3341053	A549	lung:	n/a	n/a
21	CREB1	chr7:3340365-3341037	HepG2	liver:	n/a	n/a
22	CTBP2	chr7:3340345-3341019	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr7:3340484-3340725	MCF-7	breast:	n/a	n/a
24	CTCF	chr7:3340433-3340874	A549	lung:	n/a	chr7:3340483-3340496
25	CTCF	chr7:3340496-3340772	GM10248	blood:	n/a	n/a
26	CTCF	chr7:3340453-3340772	GM19238	blood:	n/a	chr7:3340483-3340496
27	CTCF	chr7:3340280-3340430	AG04450	lung:	n/a	n/a
28	CTCF	chr7:3340580-3340730	HAc	cerebellar:	n/a	n/a
29	CTCF	chr7:3340465-3340747	GM19239	blood:	n/a	chr7:3340483-3340496
30	CTCF	chr7:3340360-3340380	GM19240	blood:	n/a	n/a
31	CTCF	chr7:3340294-3340348	GM10248	blood:	n/a	n/a
32	CTCF	chr7:3340560-3340710	GM12878	blood:	n/a	n/a
33	CTCF	chr7:3342037-3342219	Pancreas_OC	pancreas:	n/a	n/a
34	CTCF	chr7:3340396-3340852	GM12878	blood:	n/a	chr7:3340483-3340496
35	CTCF	chr7:3340418-3340769	T-47D	breast:	n/a	chr7:3340483-3340496
36	CTCF	chr7:3340560-3340710	K562	blood:	n/a	n/a
37	CTCF	chr7:3340393-3340825	H1-hESC	embryonic stem cell:	n/a	chr7:3340483-3340496
38	CTCF	chr7:3341950-3342130	MCF-7	breast:	n/a	n/a
39	CTCF	chr7:3340444-3340765	A549	lung:	n/a	chr7:3340483-3340496
40	CTCF	chr7:3341979-3342089	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr7:3341858-3342364	MCF-7	breast:	n/a	n/a
42	CTCF	chr7:3342060-3342210	SAEC	small airway:	n/a	n/a
43	CTCF	chr7:3340540-3340690	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr7:3342000-3342150	AG09319	gingival:	n/a	n/a
45	CTCF	chr7:3340540-3340690	HCT-116	colon:	n/a	n/a
46	CTCF	chr7:3340560-3340710	HMEC	breast:	n/a	n/a
47	CTCF	chr7:3342040-3342190	Hela-S3	cervix:	n/a	n/a
48	CTCF	chr7:3340240-3340390	HBMEC	blood vessel:	n/a	n/a
49	CTCF	chr7:3340503-3340768	SK-N-SH_RA	brain:	n/a	n/a
50	CTCF	chr7:3340580-3340730	HVMF	connective:	n/a	n/a

(count:613 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:3341875-3341925	CMK	blood:	n/a
2	chr7:3341934-3341984	T-47D	breast:	n/a
3	chr7:3340866-3340916	AoSMC	blood vessel:	n/a
4	chr7:3341875-3341925	CMK	blood:	n/a
5	chr7:3341934-3341984	T-47D	breast:	n/a
6	chr7:3340866-3340916	AoSMC	blood vessel:	n/a
7	chr7:3341694-3341744	AG04450	lung:	fetal
8	chr7:3340860-3340910	HRCEpiC	kidney:	n/a
9	chr7:3340860-3340910	ProgFib	skin:	n/a
10	chr7:3341934-3341984	Hela-S3	cervix:	n/a
11	chr7:3341524-3341574	AG10803	skin:	n/a
12	chr7:3341524-3341574	BJ	skin:	n/a
13	chr7:3342048-3342098	HCPEpiC	choroid plexus:	n/a
14	chr7:3341630-3341680	NB4	blood:	n/a
15	chr7:3341875-3341925	SK-N-SH_RA	brain:	n/a
16	chr7:3341524-3341574	GM06990	blood:	n/a
17	chr7:3341934-3341984	A549	lung:	n/a
18	chr7:3341630-3341680	MCF-7	breast:	n/a
19	chr7:3341875-3341925	HCM	heart:	n/a
20	chr7:3340459-3340509	AG09309	skin:	n/a
21	chr7:3342048-3342098	HUVEC	blood vessel:	n/a
22	chr7:3340979-3341029	HCT-116	colon:	n/a
23	chr7:3340979-3341029	GM06990	blood:	n/a
24	chr7:3341524-3341574	IMR90	lung:	fetal
25	chr7:3341694-3341744	HMEC	breast:	n/a
26	chr7:3341524-3341574	AoSMC	blood vessel:	n/a
27	chr7:3340860-3340910	HRE	kidney:	n/a
28	chr7:3342048-3342098	HRCEpiC	kidney:	n/a
29	chr7:3340979-3341029	Hepatocyte	liver:	n/a
30	chr7:3340860-3340910	HPAEpiC	pulmonary alveolar:	n/a
31	chr7:3341524-3341574	HRE	kidney:	n/a
32	chr7:3342048-3342098	SKMC	muscle:	n/a
33	chr7:3341875-3341925	NT2-D1	testis:	n/a
34	chr7:3341630-3341680	HL-60	blood:	n/a
35	chr7:3341934-3341984	SKMC	muscle:	n/a
36	chr7:3340860-3340910	HepG2	liver:	n/a
37	chr7:3341630-3341680	CMK	blood:	n/a
38	chr7:3341524-3341574	HIPEpiC	eye:	n/a
39	chr7:3341934-3341984	AG04449	skin:	fetal
40	chr7:3341524-3341574	HMEC	breast:	n/a
41	chr7:3340979-3341029	GM19239	blood:	n/a
42	chr7:3340866-3340916	ovcar-3	ovarian:	n/a
43	chr7:3341524-3341574	AG04449	skin:	fetal
44	chr7:3340459-3340509	HNPCEpiC	eye:	n/a
45	chr7:3340866-3340916	Caco-2	colon:	n/a
46	chr7:3340979-3341029	IMR90	lung:	fetal
47	chr7:3342048-3342098	LNCaP	prostate:	n/a
48	chr7:3340866-3340916	NHDF-neo	bronchial:	n/a
49	chr7:3341630-3341680	HAEpiC	amniotic membrane:	n/a
50	chr7:3341630-3341680	Caco-2	colon:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:3250247..3250807-chr7:3340190..3341077,3	MCF-7	breast:
2	chr7:3340063..3340822-chr7:3439252..3440083,5	MCF-7	breast:
3	chr7:3194510..3195232-chr7:3340158..3340723,2	MCF-7	breast:
4	chr7:3339718..3341766-chr7:3458306..3459954,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC091801.1.1-6	chr7:3341861-3342084	ENSG00000236708.1

No data

Variant related genes	Relation type
SDK1	TF binding region
ENSG00000236708	TF binding region
SDK1	CpG island
ENSG00000236708	CpG island
ENSG00000211544	chromatin interactions

Extended variants
information (count: 92 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:92 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10261250	chr7:3340187-3340188	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs537474556	chr7:3340199-3340200	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs557663122	chr7:3340217-3340218	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs62437664	chr7:3340248-3340249	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs540011481	chr7:3340266-3340267	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs553254368	chr7:3340354-3340355	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs573391340	chr7:3340356-3340357	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs541534226	chr7:3340397-3340398	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs555059571	chr7:3340400-3340401	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs574880397	chr7:3340428-3340429	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs543834090	chr7:3340460-3340461	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs564037149	chr7:3340464-3340465	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs533036572	chr7:3340487-3340488	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs115231328	chr7:3340531-3340532	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs371998776	chr7:3340555-3340556	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs560060833	chr7:3340560-3340561	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs181946163	chr7:3340576-3340577	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs114377917	chr7:3340577-3340578	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs530921861	chr7:3340586-3340587	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs551033491	chr7:3340602-3340603	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs570836666	chr7:3340612-3340613	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs539700909	chr7:3340622-3340623	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs112028917	chr7:3340683-3340684	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs553653413	chr7:3340712-3340713	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs566920122	chr7:3340757-3340758	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs375266803	chr7:3340776-3340777	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs147487727	chr7:3340795-3340796	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs555023745	chr7:3340838-3340839	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs12671946	chr7:3340840-3340841	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs543795656	chr7:3340853-3340854	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs184390056	chr7:3340866-3340867	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs540876108	chr7:3340910-3340911	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs550424610	chr7:3340912-3340913	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs13231855	chr7:3340969-3340970	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs189148377	chr7:3340971-3340972	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs117556406	chr7:3340974-3340975	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs540120777	chr7:3341050-3341051	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs560430423	chr7:3341216-3341217	Weak transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs10228086	chr7:3341390-3341391	Weak transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs369731384	chr7:3341456-3341457	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs542888434	chr7:3341461-3341462	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs562152366	chr7:3341582-3341583	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs200298749	chr7:3341590-3341591	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs111765287	chr7:3341609-3341610	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs10238520	chr7:3341615-3341616	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs145216539	chr7:3341631-3341632	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs533380577	chr7:3341659-3341660	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs546963856	chr7:3341661-3341662	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs567182580	chr7:3341662-3341663	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs547962604	chr7:3341664-3341665	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Chordoma	21602918	CNVD
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Nasopharyngeal cancer	20548289	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
Spondylocostal dysostosis	21085971	CNVD
Mental retardation	17901693	CNVD
Heart disease	21282601	CNVD
Glioblastoma multiforme	22286061	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Colorectal cancer	21645411	CNVD
Intellectual disability	21811512	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:431 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:3338600-3340200	Enhancers	NHDF-Ad	bronchial
2	chr7:3339400-3340200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
3	chr7:3339400-3340200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
4	chr7:3339400-3340200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
5	chr7:3339400-3340200	Bivalent Enhancer	Fetal Thymus	thymus
6	chr7:3339400-3340600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
7	chr7:3339400-3340600	Bivalent Enhancer	Placenta	Placenta
8	chr7:3339600-3340200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
9	chr7:3339600-3340200	Bivalent Enhancer	Fetal Stomach	stomach
10	chr7:3339600-3340200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
11	chr7:3339600-3342600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
12	chr7:3339800-3340200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr7:3339800-3340200	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr7:3339800-3340200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr7:3339800-3340200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
16	chr7:3339800-3340200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr7:3339800-3340200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr7:3339800-3340200	Bivalent Enhancer	Primary B cells from cord blood	blood
19	chr7:3339800-3340200	Bivalent Enhancer	Primary T cells from cord blood	blood
20	chr7:3339800-3340200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
21	chr7:3339800-3340200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
22	chr7:3339800-3340200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr7:3339800-3340200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr7:3339800-3340200	Enhancers	Liver	Liver
25	chr7:3339800-3340200	Enhancers	Brain Angular Gyrus	brain
26	chr7:3339800-3340200	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
27	chr7:3339800-3340200	Bivalent Enhancer	Fetal Lung	lung
28	chr7:3339800-3340200	Bivalent Enhancer	Fetal Muscle Leg	muscle
29	chr7:3339800-3340200	Flanking Active TSS	Pancreas	Pancrea
30	chr7:3339800-3340200	Flanking Active TSS	Right Ventricle	heart
31	chr7:3339800-3340200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
32	chr7:3339800-3340200	Bivalent Enhancer	Thymus	Thymus
33	chr7:3339800-3340400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
34	chr7:3339800-3340400	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr7:3339800-3340400	Enhancers	Primary hematopoietic stem cells	blood
36	chr7:3339800-3340400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
37	chr7:3339800-3340400	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr7:3339800-3340400	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr7:3339800-3340400	Flanking Active TSS	Brain Cingulate Gyrus	brain
40	chr7:3339800-3340600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
41	chr7:3339800-3340600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
42	chr7:3339800-3340600	Active TSS	Brain Substantia Nigra	brain
43	chr7:3339800-3340600	Enhancers	Fetal Brain Male	brain
44	chr7:3339800-3341600	Active TSS	Fetal Brain Female	brain
45	chr7:3339800-3342200	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
46	chr7:3339800-3342200	Active TSS	HSMMtube	muscle
47	chr7:3340000-3340200	Flanking Active TSS	ES-WA7 Cell Line	embryonic stem cell
48	chr7:3340000-3340200	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr7:3340000-3340200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
50	chr7:3340000-3340200	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links